Summary:
Phase 3 multi-center Randomizaed Double-Blind Study to evaluate the safety and efficacy for an invstigational medication to treat Anxiety Disorder.
Criteria:- Be willing to take an investigational medication to treat Anxiety or Panic Attacks.
- Be between ages 18-65.
- Have Moderate-Severe symptoms of anxiety.
- Be willing to discontinue current psychiatric medications.
Qualified Participants May Receive:
- Compensation for time and travel up to $1,000.
- Study related care and medication at no cost.
- No insurance necessary in order to qualify.